Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications
- PMID: 40755762
- PMCID: PMC12313687
- DOI: 10.3389/fimmu.2025.1604271
Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications
Abstract
Suppressor of cytokine signaling (SOCS) is a family of regulatory factors whose expression can be induced by various cytokines, growth factors, and hormones. Autoimmune diseases, chronic inflammatory conditions caused by abnormal immune responses, involve overactive T-cells and B-cells, excessive autoantibody production, and damage to multiple organs and systems. The pathogenic mechanisms of autoimmune diseases are complex, and SOCS proteins, particularly SOCS1, SOCS2, SOCS3, and SOCS5, regulate cytokine receptor signaling through distinct mechanisms, thereby participating in the development and progression of autoimmune diseases. This positions SOCS proteins as potential therapeutic targets for modulating dysregulated immune responses in autoimmune diseases.
Keywords: JAK-STAT; SOCS; autoimmune diseases; cytokines; immunity.
Copyright © 2025 Cui and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Suppressor of Cytokine Signaling Mimetics as a Therapeutic Approach in Autoimmune Encephalitis.Eur J Immunol. 2025 Aug;55(8):e70023. doi: 10.1002/eji.70023. Eur J Immunol. 2025. PMID: 40770863 Review.
-
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.Eur J Immunol. 2014 May;44(5):1265-75. doi: 10.1002/eji.201344369. Epub 2014 Mar 27. Eur J Immunol. 2014. PMID: 24595859 Review.
-
SOCS Proteins: Key Players in Immune Regulation During SARS-CoV-2 Infection.Eur J Immunol. 2025 Aug;55(8):e51645. doi: 10.1002/eji.202451645. Eur J Immunol. 2025. PMID: 40844207 Free PMC article. Review.
-
The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances.Front Immunol. 2025 Jun 6;16:1538555. doi: 10.3389/fimmu.2025.1538555. eCollection 2025. Front Immunol. 2025. PMID: 40547016 Free PMC article. Review.
-
Targeting the JAK/STAT3/SOCS signaling pathway in Alzheimer's disease.Inflammopharmacology. 2025 Jun;33(6):2951-2962. doi: 10.1007/s10787-025-01796-w. Epub 2025 Jun 3. Inflammopharmacology. 2025. PMID: 40461755 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical